Shield Therapeutics is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a composition of matter patent protecting the active substance of Feraccru.
Please use the link provided below for the full announcement.
US Composition of Matter Patent Press Release
Back to news